Market Place
Sourcing Support
Study on Nalmefene, Naloxone for Fentanyl Respiratory Depression
28 Oct 2024 //
BUSINESSWIRE
Harm Reduction Therapeutics Donates RiVive Naloxone on Overdose Awareness Day
03 Sep 2024 //
GLOBENEWSWIRE
Hikma Participates In Naloxone Training With Congressman
20 Aug 2024 //
PR NEWSWIRE
Medea Partners With CalOptima To Distribute Naloxone In Southern California
13 Aug 2024 //
BUSINESSWIRE
This Must Be The Place And Walgreens Expand Naloxone Access
08 Aug 2024 //
BUSINESSWIRE
Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution
06 Aug 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Launches Opioid Emergency Campaign With Emmitt Smith
24 Jul 2024 //
GLOBENEWSWIRE
US FDA declines to approve Orexo`s opioid overdose drug
17 Jul 2024 //
REUTERS
Emergent Drives Progress Against Opioid Epidemic On Naloxone Day
06 Jun 2024 //
GLOBENEWSWIRE
Amneal Launches OTC Naloxone In US Retail, California
22 May 2024 //
BUSINESSWIRE
Purdue Pharma partners with MMCAP Infuse to provide low-cost opioid use disorder
08 May 2024 //
PHARMABIZ
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
04 May 2024 //
REUTERS
Amneal`s OTC Naloxone Nasal Spray Approved
24 Apr 2024 //
BUSINESSWIRE
Amneal Pharm Generic Naloxone Hydrochloride Receives Approval in the U.S.
23 Apr 2024 //
FDA
Emergent Continues to Awareness and Availability of NARCAN® Nasal Spray
28 Mar 2024 //
GLOBENEWSWIRE
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making
30 Aug 2023 //
GLOBENEWSWIRE
Wexler Boley & Elgersma LLP, Miller Law LLC, Hilliard Shadowen LLP, Motley Rice
28 Aug 2023 //
PR NEWSWIRE
OTC naloxone to cost about as much as the brand-name, prescription version
09 Aug 2023 //
ENDPTS
Orexo wins patent litigation for ZUBSOLV® in the US
01 Jul 2023 //
PR NEWSWIRE
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
Operation UNITE and HarborPath Awarded $1 Million Grant to Fund Naloxone-Plus
27 Apr 2023 //
BUSINESSWIRE
FDA Confirms Paragraph IV Patent Litigation for Naloxone Hydrochloride
25 Apr 2023 //
FDA
Heart to Heart CPR Now Offering Free Naloxone Kits and Opioid Response Training
31 Mar 2023 //
GLOBENEWSWIRE
Emergent makes history with first FDA nod for over-the-counter naloxone
30 Mar 2023 //
FIERCE PHARMA
Amphastar Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg
08 Mar 2023 //
ACCESSWIRE
Amneal Announces FDA Filing Acceptance of NDA for Naloxone HCL Nasal Spray
02 Mar 2023 //
BUSINESSWIRE
FDA expert panel unanimously backs over-the-counter Narcan nod
16 Feb 2023 //
FIERCE PHARMA
Should Narcan spray be sold over counter? FDA poses potential packaging changes
13 Feb 2023 //
ENDPTS
Orexo seeks approval of nasal high-dose opioid rescue medicine
08 Feb 2023 //
FIERCE PHARMA
Harm Reduction Therapeutics` NDA for RiVive™ OTC Naloxone Nasal Spray
26 Dec 2022 //
PRNEWSWIRE
U.S. FDA to review Emergent`s OTC opioid overdose drug on priority
07 Dec 2022 //
BIOSPACE
Emergent Announces U.S. FDA Acceptance & Review of SNDA for OTC NARCANA
06 Dec 2022 //
GLOBENEWSWIRE
Naloxone Startup Pursues FDA Approval for Over-the-Counter Swab
02 Dec 2022 //
WSJ
NaxSwab OTC novel naloxone nasal swab demonstrates faster absorption
01 Dec 2022 //
PRNEWSWIRE
FDA Announces that Naloxone Products Have Potential to be Safe for Counter Use
15 Nov 2022 //
PRNEWSWIRE
Enforcement Report - Week of November 9, 2022
09 Nov 2022 //
FDA
Baxter`s Generic Naloxone Hydrochloride Receives Approval in the U.S.
07 Nov 2022 //
FDA
Accord`s Generic Cabazitaxel Receives Approval in the U.S.
26 Oct 2022 //
FDA
Walmart to pay $215 million to settle Florida opioid claims
20 Oct 2022 //
FIRSTWORDPHARMA
Naloxone Initiates a Rolling Submission of its NDA to U.S.FDA for RiVive
11 Oct 2022 //
PRNEWSWIRE
FDA exempts naloxone distribution from DSCSA tracking requirements
23 Sep 2022 //
RAPS
Naloxone Product Giving People Hope to Help Combat Growing Opioid Overdose Trend
31 Aug 2022 //
BUSINESSWIRE
Indivior fails to escape class action lawsuit in Suboxone case
24 Aug 2022 //
ENDPTS
Harm Reduction Therapeutics Signs Supply Agreement for Fast Tracked Naloxone
11 Aug 2022 //
PRNEWSWIRE
Par Sterile Products Generic Naloxone HCL Receives Approval Approval in U.S.
29 Jul 2022 //
FDA
HarborPath Selects FFF Enterprises as Exclusive Distributor for Naloxone
07 Jul 2022 //
BUSINESSWIRE
Padagis Announces 3 Major Product Launches
21 Jun 2022 //
FDA
Padagis`s Generic Naloxone Hydrochloride Receives Approval in US
21 Jun 2022 //
FDA
Hikma Pharmaceuticals Generic Naloxone HCL Receives Approval in the U.S.
10 Jun 2022 //
FDA
Mylan Labs Generic Naloxone Hydrochloride Receives Approval in the U.S.
09 Jun 2022 //
FDA
Aveva`s Generic Buprenorphine HCL Naloxone HCL Receives Approval in the U.S.
02 Jun 2022 //
FDA
Opiant Pharma Shows Topline Results Comparing Nasal Nalmefene to Nasal Naloxone
27 Apr 2022 //
GLOBENEWSWIRE
A $2.1 million price tag for Bluebird Bio’s gene therapy is cost-effective
14 Apr 2022 //
STATNEWS
Purdue shells out a little more cash for naloxone OTC nasal spray
30 Mar 2022 //
ENDPTS
HRT to Receive Additional Funding for OTC Naloxone Nasal Spray
23 Mar 2022 //
BUSINESSWIRE
FDA Approves Kaléo’s 10 mg Naloxone Auto-Injector for Weaponized Opioids
02 Mar 2022 //
BUSINESSWIRE
Harm Reduction Tx Says Naloxone Nasal Spray Met Its Primary Endpoints in Phase 1
01 Mar 2022 //
PRNEWSWIRE
